Wolters Kluwer

Wolters Kluwer is the Dutch professional-information-services group operating across four divisions: Health (clinical decision support, UpToDate), Tax & Accounting (CCH tax compliance and ERP), Governance, Risk and Compliance (regulatory compliance for banks and legal firms), and Legal & Regulatory. The business model is the kind that quality investors fall in love with: roughly 80% of revenue is now recurring subscription, software-as-a-service, or contractual, with retention rates above 95% for the major UpToDate, CCH Axcess, and Lippincott offerings. The 2025 narrative was a slow but persistent thesis confirmation: organic revenue growth held at 6-7% even through a US tax-software cyclical slowdown, EBITA margin expanded to roughly 27.5%, and free cash flow exceeded 1.4 billion EUR. The 2026 story is the AI-driven product upgrade cycle. UpToDate (medical decision-support, used by roughly 2.4 million clinicians globally) launched a fully GenAI-enhanced version in late 2025 priced at a 20-25% upsell. CCH Axcess for tax professionals now embeds AI-assisted document review. Each AI upgrade modestly lifts ARPU and dramatically raises switching costs. FY2026 guidance is for organic revenue growth of 6-7%, EBITA margin expansion to roughly 28%, and adjusted free cash flow of 1.5 billion EUR.

Wolters Kluwer is one of the most-held names in European quality-compounder portfolios. Active institutional holders include Fundsmith (Terry Smith has held since 2013, top 10 position), Lindsell Train, Comgest, and Capital Group. UK quality-investor Stewart Investors has been a multi-year holder. The family of Wolters Kluwer's founders no longer holds a controlling stake, but the supervisory-board governance has historically prevented hostile activism. The bear camp on Wolters Kluwer is small: shorts focus on the risk that genuine AI competition (specialised legal-research startups, OpenAI medical-vertical applications) could erode UpToDate's pricing power. So far this thesis has not materialised, but it remains a credible long-term threat.

Wolters Kluwer trades at 28× forward earnings, 6.5× forward EV/revenue, and 22× forward EV/EBITDA. All three multiples are premium to general European software but justified by the recurring-revenue quality and AI upside. Free-cash-flow yield is approximately 3.5%, with strong trajectory toward 4.5% over the next three years as EBITA margin continues expanding. Bull case (AI upsell drives 8% organic growth, margin to 30%): EUR 195. Base case (Steady 6-7% growth, margin to 28%): EUR 165. Bear case (AI competition emerges, tax cyclical pressure, multiple to 24×): EUR 115.

1. August 2026: H1/2026 results — first full half with meaningful AI-enhanced product contribution; watch UpToDate AI adoption metrics.
2. November 2026: Q3/2026 trading update — visibility into 2027 organic growth trajectory and US tax-software pipeline.
3. February 2027: FY2026 results plus dividend proposal — expected continued mid-single-digit dividend hike, marking another year of compounding.

Wolters Kluwer is in my European quality-compounder sleeve at 2.2% portfolio weight. The thesis is the most boring kind of bull case: dominant verticals, 80% recurring revenue, retention above 95%, steady AI-driven ARPU expansion, and consistent 5% total shareholder yield. Where I'd be cautious for new entries: the valuation is rich and the multiple-expansion phase is behind us — future returns are driven by earnings growth and capital return, not by re-rating. Add on weakness (any 8-12% pullback from peak), avoid chasing strength. Compared with RELX (similar quality, similar valuation, but more dependent on Elsevier journals) and Experian (more cyclical credit-bureau exposure), Wolters Kluwer offers the cleanest professional-information-services exposure. This is a 5-10 year position for investors who value consistent compounding over thematic stories.